CSLT

NYSE:CSLT

Castlight Health

  • Stock

USD

Last Close

2.04

01/01 00:00

PE Ratio

−4.99

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
average inventory
average payables
2.38M
-
2.88M
20.89%
3.30M
14.74%
2.84M
14.07%
3.10M
9.22%
6.73M
117.32%
14.58M
116.53%
12.37M
15.13%
average receivables
3.89M
-
8.43M
116.76%
12.37M
46.82%
13.96M
12.82%
17.78M
27.40%
23.79M
33.77%
29.11M
22.36%
31.57M
8.46%
book value per share
0.75
-
2.37
214.17%
1.26
46.71%
1.01
19.87%
1.40
38.07%
1.41
1.24%
1.19
15.78%
0.82
31.33%
capex per share
-0.03
-
-0.03
28.11%
-0.06
129.31%
-0.02
70.55%
-0.02
20.02%
-0.01
27.82%
-0.01
8.03%
-0.02
75.68%
capex to depreciation
-4.09
-
-1.37
66.39%
-2.66
93.35%
-0.54
79.77%
-0.38
28.39%
-0.29
23.66%
-0.33
12.34%
-0.55
66.01%
capex to operating cash flow
0.05
-
0.03
34.12%
0.09
177.69%
0.05
51.30%
0.11
135.58%
0.11
0.10%
0.11
3.43%
0.64
472.88%
capex to revenue
-0.20
-
-0.04
79.55%
-0.07
75.02%
-0.02
76.55%
-0.02
15.66%
-0.01
33.47%
-0.01
5.83%
-0.02
79.06%
cash per share
0.90
-
2.59
186.52%
1.28
50.36%
1.14
11.48%
0.74
34.60%
0.56
24.47%
0.41
27.11%
0.33
20.59%
days of inventory on hand
days payables outstanding
53.49
-
42.28
20.96%
36.58
13.49%
24.16
33.94%
30.22
25.08%
57.95
91.74%
121.08
108.94%
36.08
70.20%
days sales outstanding
146.89
-
93.11
36.61%
63.54
31.75%
53.14
16.38%
57.66
8.50%
62.58
8.54%
79.97
27.78%
78.97
1.25%
debt to assets
0.33
-
0.21
35.83%
0.32
50.30%
0.35
10.82%
0.30
15.52%
0.23
21.78%
0.29
24.06%
0.26
10.66%
debt to equity
0.49
-
0.27
45.40%
0.46
73.64%
0.54
16.68%
0.42
22.06%
0.30
28.37%
0.40
33.79%
0.35
14.34%
dividend yield
earnings yield
-0.02
-
-0.10
370.08%
-0.20
102.16%
-0.12
41.22%
-0.12
0.60%
-0.13
12.58%
-0.21
55.90%
-0.32
52.42%
enterprise value
2.93B
-
852.83M
70.94%
381.18M
55.30%
450.23M
18.12%
446.42M
0.85%
247.35M
44.59%
157.37M
36.38%
160.91M
2.25%
enterprise value over ebitda
-47.68
-
-10.08
78.86%
-4.89
51.47%
-8.13
66.14%
-8.24
1.38%
-7.53
8.63%
-4.62
38.68%
-2.89
37.37%
ev to operating cash flow
-58.62
-
-15.61
73.37%
-6.70
57.06%
-12.18
81.68%
-19.03
56.28%
-13.33
29.94%
-9.05
32.14%
-28.92
219.56%
ev to sales
226.22
-
18.70
91.73%
5.06
72.94%
4.43
12.53%
3.40
23.27%
1.58
53.44%
1.10
30.56%
1.10
0.12%
free cash flow per share
-0.71
-
-0.76
7.29%
-0.66
12.59%
-0.38
42.21%
-0.21
46.02%
-0.15
27.89%
-0.13
10.78%
-0.06
54.69%
free cash flow yield
-0.02
-
-0.06
264.97%
-0.16
139.50%
-0.08
50.15%
-0.06
28.74%
-0.07
24.62%
-0.10
45.56%
-0.05
53.65%
graham net net
0.59
-
2.07
253.10%
0.80
61.22%
0.70
12.96%
0.28
60.21%
0.28
0.74%
0.09
67.90%
0.20
121.08%
graham number
3.77
-
7.85
108.36%
4.92
37.29%
3.64
26.11%
3.73
2.58%
3.03
18.79%
2.72
10.29%
2.75
1.14%
income quality
0.81
-
0.64
21.04%
0.71
11.92%
0.63
11.26%
0.42
33.15%
0.47
10.68%
0.43
6.94%
0.09
79.42%
intangibles to total assets
0
-
0
0
0
0.45
Infinity%
0.43
5.21%
0.43
0.52%
0.30
30.79%
interest coverage
interest debt per share
0.04
-
0.02
40.16%
0.05
113.03%
0.09
73.54%
inventory turnover
invested capital
0.03
-
0.02
40.89%
0.04
152.94%
0.11
152.72%
market cap
2.96B
-
870.26M
70.60%
400.33M
54.00%
498.95M
24.64%
470.75M
5.65%
298.78M
36.53%
193.08M
35.38%
196.92M
1.99%
net current asset value
50.02M
-
163.65M
227.14%
87.47M
46.55%
85.81M
1.90%
50.52M
41.12%
48.98M
3.04%
25.56M
47.82%
41.88M
63.83%
net debt to ebitda
0.41
-
0.21
49.59%
0.25
19.34%
0.88
257.86%
0.45
48.93%
1.57
248.43%
1.05
33.08%
0.65
38.24%
net income per share
-0.84
-
-1.16
38.19%
-0.85
26.22%
-0.58
31.86%
-0.44
23.79%
-0.29
34.86%
-0.28
4.45%
-0.41
48.98%
operating cash flow per share
-0.67
-
-0.73
9.12%
-0.61
17.42%
-0.37
39.53%
-0.19
49.05%
-0.13
27.89%
-0.12
11.08%
-0.04
69.33%
payables turnover
6.82
-
8.63
26.52%
9.98
15.59%
15.11
51.38%
12.08
20.05%
6.30
47.85%
3.01
52.14%
10.12
235.54%
receivables turnover
2.48
-
3.92
57.76%
5.74
46.53%
6.87
19.58%
6.33
7.84%
5.83
7.87%
4.56
21.74%
4.62
1.27%
research and ddevelopement to revenue
1.17
-
0.50
57.16%
0.40
20.53%
0.40
0.38%
0.41
4.24%
0.39
5.40%
0.41
4.94%
0.34
18.10%
return on tangible assets
-0.74
-
-0.38
48.30%
-0.46
19.83%
-0.37
19.23%
-0.40
8.68%
-0.27
32.60%
-0.29
5.61%
-0.53
83.88%
revenue per share
0.17
-
0.61
251.49%
0.80
31.02%
1.01
25.60%
1.05
3.77%
1.14
8.50%
0.99
13.10%
0.97
1.89%
roe
-1.11
-
-0.49
56.02%
-0.68
38.44%
-0.57
14.96%
-0.32
44.80%
-0.20
35.65%
-0.23
13.45%
-0.50
116.95%
roic
-2.03
-
-0.47
77.11%
-0.61
31.04%
-1.03
68.46%
-0.46
55.47%
-0.36
22.07%
-0.30
15.42%
-0.99
229.83%
sales general and administrative to revenue
0.70
-
0.42
40.23%
0.32
22.68%
0.26
18.06%
0.22
16.96%
0.16
25.31%
0.20
19.20%
0.17
10.41%
shareholders equity per share
0.75
-
2.37
214.17%
1.26
46.71%
1.01
19.87%
1.40
38.07%
1.41
1.24%
1.19
15.78%
0.82
31.33%
stock based compensation to revenue
0.19
-
0.31
66.45%
0.24
23.97%
0.22
8.57%
0.19
13.60%
0.12
38.01%
0.10
9.70%
0.08
18.97%
tangible asset value
56.07M
-
176.19M
214.22%
118.35M
32.83%
101.96M
13.85%
63.28M
37.93%
86.68M
36.97%
68.91M
20.50%
74.45M
8.04%
tangible book value per share
0.75
-
2.37
214.17%
1.26
46.71%
1.01
19.87%
0.50
50.16%
0.63
24.88%
0.47
24.60%
0.49
3.54%
working capital
54.94M
-
170.56M
210.42%
96.38M
43.49%
92.29M
4.25%
64.06M
30.58%
56.65M
11.57%
40.56M
28.40%
50.47M
24.42%

All numbers in USD (except ratios and percentages)